DRUG WATCH |
|
Year : 2023 | Volume
: 55
| Issue : 5 | Page : 332-334 |
Extensive arm skin necrosis following administration of unfractionated heparin
Dena Firouzabadi1, Peyman Petramfar2, Laleh Mahmoudi3
1 Department of Clinical Pharmacy, School of Pharmacy; Department of Clinical Pharmacy, Shahid Faghihi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran 2 Department of Neurology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran 3 Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
Correspondence Address:
Laleh Mahmoudi Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz Iran
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijp.ijp_311_23
Unfractionated heparin (UH), a commonly used anticoagulant, can rarely cause skin necrosis following heparin-induced thrombocytopenia (HIT). A 38-year-old female, a case of chronic inflammatory demyelinating polyneuropathy (CIDP) admitted to the neurology ward, developed extensive skin necrosis following a change in UH dose at the exact site of UH injection. A sudden fall in the platelet count was observed within 48 h of increasing the UH dose. Necrosis of the outer layer of the skin along with clot formation and inflammation in the inner layers was detected after histopathological evaluation. UH was discontinued, and rivaroxaban was started for the patient as soon as the complication was detected. The patient was discharged in good condition after completing treatment for CIDP without any need for surgical removal of the necrotic tissue. Extensive skin necrosis, as a result of HIT, requires immediate discontinuation of UH and substitution of a nonheparin-based anticoagulation treatment.
[FULL TEXT] [PDF]*
|